One of the global health concerns is allergic rhinitis which affects 400 million people worldwide. Approximately, 25% of children and 40% of adults are affected by it.1 Allergic rhinitis (AR) is described by symptoms such as nasal congestion/obstruction, rhinorrhea, sneezing and pruritus resulting from dysfunction of the nasal mucosa and/or nasal inflammation.2 About 80% of AR symptoms occur before the age of 20 years and they peak between 20–40 years. Over the first 5 years of life, incidence rate of AR among children is reported to be 17.2%. Additionally, the incidence rate of AR in children with the peak age at diagnosis between 24 and 29 months is 2.5%.1 In India, approximately 22% of adolescents currently suffer from AR.